Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Revenue

Tatva Chintan Pharma Chem had revenue of 2.17B INR in the quarter ending September 30, 2026, with 75.94% growth. This brings the company's total for the last twelve months to 6.50B, up 49.69% year-over-year. In the fiscal year ending March 31, 2026, Tatva Chintan Pharma Chem had annual revenue of 5.06B with 32.18% growth. That makes Tatva Chintan Pharma Chem the 25,549th largest company in the world by revenue and 1,586th in India.

• Revenue (ttm): 6.50B
• Revenue Growth: +49.69%
• P/S Ratio: 6.80
• Revenue / Employee: 8.19M
• Employees: 793
• Market Cap: 38.48B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Overseas 3.82B 76.3%
• India 1.19B 23.7%

Fiscal year ended Mar 31, 2026 See the full Tatva Chintan Pharma Chem breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	5.06B	1.23B	32.18%
Mar 31, 2025	3.83B	-107.90M	-2.74%
Mar 31, 2024	3.94B	-301.08M	-7.11%
Mar 31, 2023	4.24B	-100.35M	-2.31%
Mar 31, 2022	4.34B	1.33B	44.38%

Data Source: S&P Global Market Intelligence Last updated: Oct 19, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error